Question

Difficulty: MediumDiagnostic Workup and Test Sequencing

A 42-year-old man presents to the clinic for a routine evaluation. He reports a 2-year history of excessive sweating, fatigue, and loud snoring that frequently wakes his spouse. He mentions that his wedding ring no longer fits and his shoe size has increased from size 10 to 12 over the past few years. He has a history of hypertension and takes amlodipine. Vital signs show a blood pressure of 152/94 mm Hg, pulse of 78/min, and BMI of 31 kg/m². Physical examination reveals coarse facial features, a prominent jaw, and a widened space between his lower incisors. His hands are enlarged and doughy. There is no visual field deficit on confrontation testing. Which of the following is the most appropriate next step in the diagnostic workup of this patient's condition?

  1. A
    Magnetic resonance imaging of the brain
  2. B
    Measurement of a random serum growth hormone level
  3. Measurement of serum insulin-like growth factor 1 levelAnswer
  4. D
    Oral glucose tolerance test with growth hormone measurement
  5. E
    Polysomnography

Answer

The most appropriate next step is the measurement of serum insulin-like growth factor 1 (IGF-1) level.
The correct answer is the measurement of serum insulin-like growth factor 1 (IGF-1) level. This patient's presentation of acral enlargement (increasing shoe and ring size), coarse facial features, hyperhidrosis, and secondary complications (hypertension, loud snoring suggesting obstructive sleep apnea) is highly suspicious for acromegaly, a syndrome caused by excess growth hormone (GH) secretion, typically from a pituitary adenoma. Because GH is secreted in a highly pulsatile fashion and has a short half-life, random serum GH levels are not reliable for screening. Instead, the initial test of choice is the measurement of serum IGF-1. IGF-1 is produced by the liver in response to GH, has a longer half-life, and provides a stable, integrated measure of GH secretion over time.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient exhibits classic signs of acromegaly, including progressive enlargement of the extremities (increasing shoe size, tight ring), coarse facial features, macrognathia, widened incisor spaces, hyperhidrosis, and secondary complications like hypertension and suspected obstructive sleep apnea.
Recognizing the syndrome is necessary to initiate the specific diagnostic algorithm.
2
Determine the appropriate initial diagnostic screening test for suspected acromegaly.
Measurement of serum IGF-1 is the initial test of choice.
Growth hormone (GH) is secreted in a highly pulsatile manner by the pituitary gland, making random GH levels uninterpretable. IGF-1 is secreted by the liver in response to GH and has a long half-life, providing a stable reflection of integrated GH secretion.
3
Sequence the subsequent diagnostic steps if the initial screen is abnormal.
If IGF-1 is elevated, the diagnosis is confirmed with an oral glucose tolerance test (OGTT) with GH measurement. Only after biochemical confirmation should an MRI of the brain (pituitary) be ordered.
Proper test sequencing prevents the pursuit of incidentalomas on imaging and ensures cost-effective, evidence-based care.

Key Concept

The initial diagnostic step for suspected acromegaly is measurement of serum insulin-like growth factor 1 (IGF-1), followed by an oral glucose tolerance test (OGTT) for confirmation, and finally an MRI of the brain to localize the pituitary adenoma.
Estimated Time:1m 0s
Rate this question